Barbara Krebs-Pohl
Corporate Officer/Principal presso MORPHOSYS AG
Provenienza dei contatti di primo grado di Barbara Krebs-Pohl
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
62
| Public Company | Biotechnology | 62 |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation.
7
| Subsidiary | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Barbara Krebs-Pohl tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer General Counsel | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Investor | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AFFIMED N.V. | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Founder Public Communications Contact | |
| University of Zurich | College/University | Corporate Officer/Principal Doctorate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
| Georgetown University | College/University | Masters Business Admin Undergraduate Degree | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| 4SC AG | Biotechnology | Investor Relations Contact Director/Board Member | |
| University of Kiel | College/University | Doctorate Degree Doctorate Degree | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Investment Managers | Founder Founder | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Chairman Director/Board Member | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Münster | College/University | Undergraduate Degree Doctorate Degree | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Griffon Pharmaceuticals, Inc.
 Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi-Aventis Recherche et Développement SA
 Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Pharmaceuticals: Major | Director/Board Member | |
| C&F Consulting | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 23 |
| Germania | 18 |
| Svizzera | 5 |
| Regno Unito | 3 |
| Francia | 3 |
Settori
| Health Technology | 30 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 255 |
| Corporate Officer/Principal | 145 |
| Independent Dir/Board Member | 85 |
| Chairman | 73 |
| Chief Executive Officer | 39 |
Contatti più connessi
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| George Golumbeski | 36 |
| Daniel Camus | 31 |
| Gerald Heinz Möller | 29 |
| Karin Eastham | 29 |
| Paul Berns | 28 |
| Wendy Johnson | 23 |
| David Lemus | 22 |
| Frank Morich | 21 |
| Hans Jörg Reinhardt | 20 |
| Sunil Agarwal | 17 |
| Geoffrey Nicholas Vernon | 17 |
| Mark Murcko | 16 |
| Klaus Kühn | 15 |
| Michael Brosnan | 14 |
- Borsa valori
- Insiders
- Barbara Krebs-Pohl
- Connessioni Società
